TY  - GEN
AU  - Stewart,A K
AU  - Vescio,R
AU  - Schiller,G
AU  - Ballester,O
AU  - Noga,S
AU  - Rugo,H
AU  - Freytes,C
AU  - Stadtmauer,E
AU  - Tarantolo,S
AU  - Sahebi,F
AU  - Stiff,P
AU  - Meharchard,J
AU  - Schlossman,R
AU  - Brown,R
AU  - Tully,H
AU  - Benyunes,M
AU  - Jacobs,C
AU  - Berenson,R
AU  - White,M
AU  - DiPersio,J
AU  - Anderson,K C
AU  - Berenson,J
TI  - Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial
SN  - 0732-183X
PY  - 2001///0920
KW  - Adult
KW  - Aged
KW  - Antigens, CD34
KW  - analysis
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Bone Marrow Purging
KW  - methods
KW  - Combined Modality Therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - immunology
KW  - Neoplastic Cells, Circulating
KW  - Polymerase Chain Reaction
KW  - Proportional Hazards Models
KW  - Survival Rate
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2001.19.17.3771
ER  -